Refinement strategy for antivenom preparation of high yield and quality.
Antivenoms from hyperimmune animal plasma are the only specific pharmaceuticals against snakebites. The improvement of downstream processing strategies is of great interest, not only in terms of purity profile, but also from yield-to-cost perspective and rational use of plasma of animal origin. We r...
Main Authors: | Tihana Kurtović, Maja Lang Balija, Marija Brgles, Dora Sviben, Monika Tunjić, Hrvoje Cajner, Martina Marchetti-Deschmann, Günter Allmaier, Beata Halassy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-06-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0007431 |
Similar Items
-
Mass spectrometry-based investigation of measles and mumps virus proteome
by: Dora Sviben, et al.
Published: (2018-10-01) -
Biological Activities and Proteomic Profile of the Venom of <i>Vipera ursinii</i> ssp., a very Rare Karst Viper from Croatia
by: Maja Lang Balija, et al.
Published: (2020-03-01) -
Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches
by: Sanja Mateljak Lukačević, et al.
Published: (2020-12-01) -
Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of <i>Vipera ammodytes</i> and <i>Vipera berus</i> Envenoming
by: Tihana Kurtović, et al.
Published: (2021-03-01) -
A Single Dose of ViperfavTM May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation
by: Tihana Kurtović, et al.
Published: (2016-08-01)